Geode Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $8.53M | Buy |
|
|||||
|
2022
Q4 | $11.5M | Buy |
|
|||||
|
2022
Q3 | $10.4M | Buy |
|
|||||
|
2022
Q2 | $9.48M | Buy |
|
|||||
|
2022
Q1 | $3.63M | Buy |
|
|||||
|
2021
Q4 | $1.69M | Buy |
|
|||||
|
2021
Q3 | $1.94M | Buy |
|
|||||
|
2021
Q2 | $1.47M | Buy |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q4 | $1.39M | Buy |
|
|||||
|
2020
Q3 | $895K | Sell |
|
|||||
|
2020
Q2 | $491K | Buy |
|
|||||
|
2020
Q1 | $382K | Buy |
|
|||||
|
2019
Q4 | $634K | Sell |
|
|||||
|
2019
Q3 | $374K | Sell |
|
|||||
|
2019
Q2 | $392K | Sell |
|
|||||
|
2019
Q1 | $612K | Sell |
|
|||||
|
2018
Q4 | $464K | Buy |
|
|||||
|
2018
Q3 | $1.35M | Buy |
|
|||||
|
2018
Q2 | $2.56M | Buy |
|
|||||
|
2018
Q1 | $1.18M | Buy |
|
|||||
|
2017
Q4 | $319K | Sell |
|
|||||
|
2017
Q3 | $620K | Buy |
|
|||||
|
2017
Q2 | $376K | Sell |
|
|||||
|
2017
Q1 | $493K | Buy |
|
|||||
|
2016
Q4 | $472K | Buy |
|
|||||
|
2016
Q3 | $424K | Buy |
|
|||||
|
2016
Q2 | $384K | Sell |
|
|||||
|
2016
Q1 | $702 | Buy |
|
|||||
|
2015
Q4 | $1.35M | Buy |
|
|||||
|
2015
Q3 | $1.44M | Buy |
|
|||||
|
2015
Q2 | $1.86M | Buy |
|
|||||
|
2015
Q1 | $1.6M | Buy |
|
|||||
|
2014
Q4 | $1.93M | Buy |
|
|||||
|
2014
Q3 | $1.93M | Buy |
|
|||||
|
2014
Q2 | $2.1M | Buy |
|
|||||
|
2014
Q1 | $2.51M | Buy |
|
|||||
|
2013
Q4 | $1.16M | Buy |
|
|||||
|
2013
Q3 | $624K | Buy |
|
|||||
|
2013
Q2 | $288K | Buy |
|